Cefepime‐induced encephalopathy: Neural mass modeling of triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC)
Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. Methods...
Saved in:
Published in | Psychiatry and clinical neurosciences Vol. 73; no. 1; pp. 34 - 42 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Melbourne
John Wiley & Sons Australia, Ltd
01.01.2019
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim
Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition.
Methods
CIE cases documented by a single‐center consultation–liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico.
Results
Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2–3 Hz Tri‐HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto‐inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri‐HNC in CIE.
Conclusion
As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri‐HNC on EEG can expedite the diagnosis of CIE, and the association between Tri‐HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction. |
---|---|
AbstractList | AIMCefepime, a fourth-generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. METHODSCIE cases documented by a single-center consultation-liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. RESULTSThree patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave-like generalized periodic discharges with a high negative component (Tri-HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2-3 Hz Tri-HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto-inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri-HNC in CIE. CONCLUSIONAs CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri-HNC on EEG can expedite the diagnosis of CIE, and the association between Tri-HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction. Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. Methods CIE cases documented by a single‐center consultation–liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. Results Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2–3 Hz Tri‐HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto‐inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri‐HNC in CIE. Conclusion As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri‐HNC on EEG can expedite the diagnosis of CIE, and the association between Tri‐HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction. Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABA A receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. Methods CIE cases documented by a single‐center consultation–liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. Results Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2–3 Hz Tri‐HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto‐inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri‐HNC in CIE. Conclusion As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri‐HNC on EEG can expedite the diagnosis of CIE, and the association between Tri‐HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction. Cefepime, a fourth-generation cephalosporin, acts as a GABA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. CIE cases documented by a single-center consultation-liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave-like generalized periodic discharges with a high negative component (Tri-HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2-3 Hz Tri-HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto-inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri-HNC in CIE. As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri-HNC on EEG can expedite the diagnosis of CIE, and the association between Tri-HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction. |
Author | Yamamoto, Naoki Hamamoto, Yu Aso, Naofumi Tamune, Hidetaka |
AuthorAffiliation | 1 Department of Neuropsychiatry Tokyo Metropolitan Tama Medical Center Tokyo Japan 3 Department of Cellular Neurobiology, Graduate School of Medicine The University of Tokyo Tokyo Japan 4 Department of Earth and Planetary Science, Graduate School of Science The University of Tokyo Tokyo Japan 5 School of Science Tokyo Institute of Technology Tokyo Japan 2 Department of Neuropsychiatry, Graduate School of Medicine The University of Tokyo Tokyo Japan |
AuthorAffiliation_xml | – name: 1 Department of Neuropsychiatry Tokyo Metropolitan Tama Medical Center Tokyo Japan – name: 3 Department of Cellular Neurobiology, Graduate School of Medicine The University of Tokyo Tokyo Japan – name: 4 Department of Earth and Planetary Science, Graduate School of Science The University of Tokyo Tokyo Japan – name: 5 School of Science Tokyo Institute of Technology Tokyo Japan – name: 2 Department of Neuropsychiatry, Graduate School of Medicine The University of Tokyo Tokyo Japan |
Author_xml | – sequence: 1 givenname: Hidetaka orcidid: 0000-0002-5581-5720 surname: Tamune fullname: Tamune, Hidetaka email: tamune-tky@umin.ac.jp organization: The University of Tokyo – sequence: 2 givenname: Yu surname: Hamamoto fullname: Hamamoto, Yu organization: The University of Tokyo – sequence: 3 givenname: Naofumi surname: Aso fullname: Aso, Naofumi organization: Tokyo Institute of Technology – sequence: 4 givenname: Naoki surname: Yamamoto fullname: Yamamoto, Naoki organization: Tokyo Metropolitan Tama Medical Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30375126$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctu1DAYhS1URC-w4AWQJTbtIq0vkxsLJBQBRaoGFmVteZw_iUtiBzuZ0bDqI3TP2_Ek_MOUCpDwJpby6dM5PsfkwHkHhDzn7JzjuRiNO-ciL9NH5IgvFizhBS8P8C6FTLjk2SE5jvGGMSZlxp-QQ8lknnKRHZHvFTQw2gF-3N5ZV88GagrOwNjp3o966rav6BLmoHs66Bjp4GvorWupb-gULGLRGrrR652gt1-AtuAAcfsNTSME62sEahtNp0MLkW7s1FFNO9t21EGrJ7sGavwwYic30dPrYFF1uazOnpLHje4jPLv_npDP795eV5fJ1cf3H6o3V4lJOU-TspEZmFJnuhSF5EIamYtFVtSpMIZnohErnkLBhBSs0I00kK7YIs0kE7VIcy5PyOu9d5xXA9QGY2ABNQY76LBVXlv19x9nO9X6tcolvrksUXB6Lwj-6wxxUgP2hb7XDvwclcBxeFmKPEX05T_ojZ-Dw3pI7SJlpWBIne0pE3yMAZqHMJyp3eQKJ1e_Jkf2xZ_pH8jfGyNwsQc2toft_03qU7XcK38C2kq8JQ |
CitedBy_id | crossref_primary_10_1002_npr2_12427 crossref_primary_10_1097_WNP_0000000000000764 crossref_primary_10_2131_jts_47_429 crossref_primary_10_1002_mds_27855 crossref_primary_10_1097_WNP_0000000000000809 crossref_primary_10_1016_j_jiac_2020_05_011 crossref_primary_10_1007_s40278_019_57725_9 |
Cites_doi | 10.1016/j.ensci.2017.08.001 10.1016/S0002-9343(01)00767-7 10.1002/ana.410100502 10.1186/s13054-017-1856-1 10.1016/j.clinph.2017.06.245 10.1016/j.clinph.2015.07.018 10.1146/annurev-pharmtox-010611-134636 10.1097/WNP.0b013e3182a73e16 10.1038/44579 10.1007/s12028-008-9166-8 10.1212/WNL.0000000000002023 10.1097/WNP.0b013e31826bde70 10.1093/ndt/gfm713 10.1136/jnnp.63.3.279 10.1038/nn.3950 10.1186/cc13094 10.1016/S0987-7053(00)00234-3 10.1016/j.expneurol.2016.05.037 10.1345/aph.1L307 10.1523/JNEUROSCI.23-29-09664.2003 10.1016/j.clinph.2013.08.005 10.1212/WNL.0000000000002455 10.1016/S0028-3908(03)00188-6 10.1212/WNL.54.11.2153 10.1592/phco.23.3.369.32100 10.1080/net.13.1.67.113 10.1111/j.1528-1167.2005.16305.x 10.1530/EDM-17-0010 10.1016/j.biopsych.2017.05.024 10.1016/j.yebeh.2015.04.007 |
ContentType | Journal Article |
Copyright | 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. 2019 The Author. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology 2018 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology |
Copyright_xml | – notice: 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology – notice: 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. – notice: 2019 The Author. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology – notice: 2018 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology |
DBID | 24P WIN NPM AAYXX CITATION 7TK K9. 7X8 5PM |
DOI | 10.1111/pcn.12795 |
DatabaseName | Wiley Online Library Wiley-Blackwell Open Access Backfiles PubMed CrossRef Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef ProQuest Health & Medical Complete (Alumni) PubMed |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Cefepime encephalopathy and Tri‐HNC |
EISSN | 1440-1819 |
EndPage | 42 |
ExternalDocumentID | 10_1111_pcn_12795 30375126 PCN12795 |
Genre | article Journal Article |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 123 1OB 1OC 24P 29P 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 7.U 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN EPS ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TKC TR2 TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH ZXP ZZTAW ~02 ~IA ~WT NPM AAYXX CITATION 7TK K9. 7X8 5PM |
ID | FETCH-LOGICAL-c5115-9f36ec9a6a9283123c372468d52cc162f2b15e8023208af3ce5b0456302d25713 |
IEDL.DBID | DR2 |
ISSN | 1323-1316 |
IngestDate | Tue Sep 17 21:21:54 EDT 2024 Fri Aug 16 01:00:54 EDT 2024 Thu Oct 10 20:38:37 EDT 2024 Fri Aug 23 03:33:19 EDT 2024 Wed Oct 16 00:52:18 EDT 2024 Sat Aug 24 01:06:39 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | electroencephalography computer simulation GABAergic neurons non-convulsive status epilepticus encephalopathy |
Language | English |
License | Attribution-NonCommercial 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5115-9f36ec9a6a9283123c372468d52cc162f2b15e8023208af3ce5b0456302d25713 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The copyright line for this article was changed on 15 August 2019 after original online publication. |
ORCID | 0000-0002-5581-5720 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpcn.12795 |
PMID | 30375126 |
PQID | 2163026920 |
PQPubID | 1106347 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7379539 proquest_miscellaneous_2127199275 proquest_journals_2163026920 crossref_primary_10_1111_pcn_12795 pubmed_primary_30375126 wiley_primary_10_1111_pcn_12795_PCN12795 |
PublicationCentury | 2000 |
PublicationDate | January 2019 |
PublicationDateYYYYMMDD | 2019-01-01 |
PublicationDate_xml | – month: 01 year: 2019 text: January 2019 |
PublicationDecade | 2010 |
PublicationPlace | Melbourne |
PublicationPlace_xml | – name: Melbourne – name: Australia – name: Tokyo |
PublicationTitle | Psychiatry and clinical neurosciences |
PublicationTitleAlternate | Psychiatry Clin Neurosci |
PublicationYear | 2019 |
Publisher | John Wiley & Sons Australia, Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons Australia, Ltd – name: Wiley Subscription Services, Inc |
References | 2017; 8 2017; 82 2015; 18 1997; 63 2002; 13 2017; 21 2016; 127 1999; 401 2005; 46 2012; 52 2016; 283 2001; 111 2015; 49 2013; 17 2009; 10 2000; 54 2015; 85 2000; 30 2013; 30 2016; 86 2008; 23 2017 2012; 29 2008; 42 2014; 125 1981; 10 2017; 128 2010; 50 2003; 45 2003; 23 e_1_2_8_28_1 e_1_2_8_29_1 Shirota Y (e_1_2_8_22_1) 2012; 52 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 Kobayakawa Y (e_1_2_8_31_1) 2010; 50 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – year: 2017 article-title: GAD antibody‐associated limbic encephalitis in a young woman with APECED publication-title: Endocrinol. Diabetes Metab. Case Rep. – volume: 401 start-page: 796 year: 1999 end-page: 800 article-title: Benzodiazepine actions mediated by specific gamma‐aminobutyric acid(A) receptor subtypes publication-title: Nature – volume: 52 start-page: 111 year: 2012 end-page: 133 article-title: Chronic pain states: Pharmacological strategies to restore diminished inhibitory spinal pain control publication-title: Annu. Rev. Pharmacol. Toxicol. – volume: 283 start-page: 57 year: 2016 end-page: 72 article-title: Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome publication-title: Exp. Neurol. – volume: 52 start-page: 356 year: 2012 end-page: 359 article-title: Severely abnormal electroencephalogram in two patients who were treated with cefepime publication-title: Clin. Neurol. – volume: 23 start-page: 369 year: 2003 end-page: 373 article-title: Retrospective review of neurotoxicity induced by cefepime and ceftazidime publication-title: Pharmacotherapy – volume: 30 start-page: 383 year: 2000 end-page: 386 article-title: Severe but reversible encephalopathy associated with cefepime publication-title: Neurophysiol. Clin. – volume: 49 start-page: 228 year: 2015 end-page: 233 article-title: Generalized periodic discharges: Pathophysiology and clinical considerations publication-title: Epilepsy Behav. – volume: 23 start-page: 966 year: 2008 end-page: 970 article-title: The neurotoxicity and safety of treatment with cefepime in patients with renal failure publication-title: Nephrol. Dial. Transplant. – volume: 17 start-page: R264 year: 2013 article-title: Cefepime neurotoxicity in the intensive care unit: A cause of severe, underappreciated encephalopathy publication-title: Crit. Care – volume: 30 start-page: 545 year: 2013 end-page: 552 article-title: Neural network modeling of EEG patterns in encephalopathy publication-title: J. Clin. Neurophysiol. – volume: 127 start-page: 1073 year: 2016 end-page: 1080 article-title: Generalized periodic discharges and “triphasic waves”: A blinded evaluation of inter‐rater agreement and clinical significance publication-title: Clin. Neurophysiol. – volume: 125 start-page: 255 year: 2014 end-page: 262 article-title: Generalized periodic discharges after acute cerebral ischemia: Reflection of selective synaptic failure? publication-title: Clin. Neurophysiol. – volume: 111 start-page: 115 year: 2001 end-page: 119 article-title: Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure publication-title: Am. J. Med. – volume: 29 start-page: 458 year: 2012 end-page: 461 article-title: Comparison of triphasic waves and epileptic discharges in one patient with genetic epilepsy publication-title: J. Clin. Neurophysiol. – volume: 21 start-page: 276 year: 2017 article-title: Cefepime‐induced neurotoxicity: A systematic review publication-title: Crit. Care – volume: 10 start-page: 405 year: 1981 end-page: 410 article-title: Virus‐induced electrotonic coupling: Hypothesis on the mechanism of periodic EEG discharges in Creutzfelt‐Jakob disease publication-title: Ann. Neurol. – volume: 50 start-page: 92 year: 2010 end-page: 97 article-title: A case of immune‐mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti‐glutamic acid decarboxylase antibody publication-title: Clin. Neurol. – volume: 45 start-page: 304 year: 2003 end-page: 314 article-title: Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins publication-title: Neuropharmacology – volume: 63 start-page: 279 year: 1997 end-page: 293 article-title: Neurology and the liver publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 128 start-page: 1682 year: 2017 end-page: 1695 article-title: Synaptic damage underlies EEG abnormalities in postanoxic encephalopathy: A computational study publication-title: Clin. Neurophysiol. – volume: 10 start-page: 347 year: 2009 end-page: 351 article-title: Cefepime‐induced nonconvulsive status epilepticus: Case report and review publication-title: Neurocrit. Care – volume: 82 start-page: 549 year: 2017 end-page: 559 article-title: Somatostatin‐positive gamma‐aminobutyric acid interneuron deficits in depression: Cortical microcircuit and therapeutic perspectives publication-title: Biol. Psychiatry – volume: 42 start-page: 1843 year: 2008 end-page: 1850 article-title: Cephalosporin‐induced neurotoxicity: Clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring publication-title: Ann. Pharmacother. – volume: 18 start-page: 351 year: 2015 end-page: 359 article-title: Microcircuits and their interactions in epilepsy: Is the focus out of focus? publication-title: Nat. Neurosci. – volume: 23 start-page: 9664 year: 2003 end-page: 9674 article-title: Major differences in inhibitory synaptic transmission onto two neocortical interneuron subclasses publication-title: J. Neurosci. – volume: 85 start-page: 1332 year: 2015 end-page: 1341 article-title: Seizures as adverse events of antibiotic drugs: A systematic review publication-title: Neurology – volume: 54 start-page: 2153 year: 2000 end-page: 2155 article-title: Status epilepticus associated with cefepime publication-title: Neurology – volume: 13 start-page: 67 year: 2002 end-page: 113 article-title: A spatially continuous mean field theory of electrocortical activity publication-title: Network: Comput. Neural Syst. – volume: 8 start-page: 40 year: 2017 end-page: 43 article-title: Cefepime induced neurotoxicity: A case series and review of the literature publication-title: eNeurologicalSci – volume: 86 start-page: 963 year: 2016 end-page: 971 article-title: Antibiotic‐associated encephalopathy publication-title: Neurology – volume: 46 start-page: 1550 year: 2005 end-page: 1552 article-title: Cephalosporin‐induced nonconvulsive status epilepticus: Clinical and electroencephalographic features publication-title: Epilepsia – ident: e_1_2_8_19_1 doi: 10.1016/j.ensci.2017.08.001 – ident: e_1_2_8_11_1 doi: 10.1016/S0002-9343(01)00767-7 – ident: e_1_2_8_20_1 doi: 10.1002/ana.410100502 – ident: e_1_2_8_23_1 doi: 10.1186/s13054-017-1856-1 – ident: e_1_2_8_8_1 doi: 10.1016/j.clinph.2017.06.245 – ident: e_1_2_8_21_1 doi: 10.1016/j.clinph.2015.07.018 – ident: e_1_2_8_27_1 doi: 10.1146/annurev-pharmtox-010611-134636 – ident: e_1_2_8_9_1 doi: 10.1097/WNP.0b013e3182a73e16 – ident: e_1_2_8_15_1 doi: 10.1038/44579 – ident: e_1_2_8_14_1 doi: 10.1007/s12028-008-9166-8 – ident: e_1_2_8_25_1 doi: 10.1212/WNL.0000000000002023 – ident: e_1_2_8_26_1 doi: 10.1097/WNP.0b013e31826bde70 – ident: e_1_2_8_18_1 doi: 10.1093/ndt/gfm713 – ident: e_1_2_8_28_1 doi: 10.1136/jnnp.63.3.279 – ident: e_1_2_8_30_1 doi: 10.1038/nn.3950 – ident: e_1_2_8_4_1 doi: 10.1186/cc13094 – ident: e_1_2_8_10_1 doi: 10.1016/S0987-7053(00)00234-3 – ident: e_1_2_8_33_1 doi: 10.1016/j.expneurol.2016.05.037 – ident: e_1_2_8_13_1 doi: 10.1345/aph.1L307 – ident: e_1_2_8_16_1 doi: 10.1523/JNEUROSCI.23-29-09664.2003 – volume: 50 start-page: 92 year: 2010 ident: e_1_2_8_31_1 article-title: A case of immune‐mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti‐glutamic acid decarboxylase antibody publication-title: Clin. Neurol. contributor: fullname: Kobayakawa Y – ident: e_1_2_8_7_1 doi: 10.1016/j.clinph.2013.08.005 – ident: e_1_2_8_2_1 doi: 10.1212/WNL.0000000000002455 – ident: e_1_2_8_3_1 doi: 10.1016/S0028-3908(03)00188-6 – ident: e_1_2_8_17_1 doi: 10.1212/WNL.54.11.2153 – ident: e_1_2_8_24_1 doi: 10.1592/phco.23.3.369.32100 – ident: e_1_2_8_6_1 doi: 10.1080/net.13.1.67.113 – volume: 52 start-page: 356 year: 2012 ident: e_1_2_8_22_1 article-title: Severely abnormal electroencephalogram in two patients who were treated with cefepime publication-title: Clin. Neurol. contributor: fullname: Shirota Y – ident: e_1_2_8_12_1 doi: 10.1111/j.1528-1167.2005.16305.x – ident: e_1_2_8_32_1 doi: 10.1530/EDM-17-0010 – ident: e_1_2_8_29_1 doi: 10.1016/j.biopsych.2017.05.024 – ident: e_1_2_8_5_1 doi: 10.1016/j.yebeh.2015.04.007 – ident: e_1_2_8_34_1 |
SSID | ssj0003361 |
Score | 2.2802205 |
Snippet | Aim
Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed... Cefepime, a fourth-generation cephalosporin, acts as a GABA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed to... Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABA A receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed... AimCefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed... AIMCefepime, a fourth-generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 34 |
SubjectTerms | Cefepime computer simulation EEG Electroencephalography Encephalopathy Firing pattern GABAergic neurons Interneurons non‐convulsive status epilepticus Pain Regular γ-Aminobutyric acid A receptors |
Title | Cefepime‐induced encephalopathy: Neural mass modeling of triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpcn.12795 https://www.ncbi.nlm.nih.gov/pubmed/30375126 https://www.proquest.com/docview/2163026920 https://search.proquest.com/docview/2127199275 https://pubmed.ncbi.nlm.nih.gov/PMC7379539 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKD4gL_9BAqQziUA5Zre3YieGEFqoVUlcVaqUekCLbcbpR22TV3QXRE4_AnbfjSZhxkqVLhYS4RYozduwZ-xt7_A0hLw0rhE68jIW2ZZz4zMUwzDJWzrtMM-t8OC7Yn6jxUfLhWB5vkDf9XZiWH2K14YaWEeZrNHBj51eMfObqAeOpxgvmTKQYzvXu42_qKCFU52yJmAmmOlYhjOJZfbm-Fl0DmNfjJK_i17AA7d0hn_qmt3Enp4Plwg7c5R-sjv_5b3fJ7Q6Y0retJt0jG76-T27ud0fvD8iPkS_9rDr3P799Bz8eNKKgOCvMpuaswbzGX19TZPoAGecAyGlIsQPrIm1KuoCZaWpAH-gX8xkFnFWnnp60jNfVJUhCvuUGqqJ4SxjJm_yc4hYxNRQJlWntTwJDOcUQ-KaGnqK7hxcViBpPRq8ekqO994ejcdxldogdADwZ61Io77RRRgO8gcXTiZQnKiskd44pXnLLpEduOj7MTCmclxaxpxjyAuYYJh6RzRoq2yK09FlRGpsJzMJkuTaidCaVVkpwlmxWRORFP8b5rCXwyHvHB7o5D90cke1-9PPOhuc5Z1if0nwYkeer12B9eKRiat8ssQxPMYA3BRGPW2VZ1SIwvTDjKiLpmhqtCiCz9_qbupoGhu9UQKOEjshu0JK_Nzw_GE3Cw5N_L_qU3ALUp9t9pG2yubhY-meArBZ2h9zgycFOMKRfBnQmSA |
link.rule.ids | 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKkYBL-YeUAgZxKIes1vbaiREXtFAt0F0htJV6QZHjON2obbJqd0H0xCNw5-14EmacH7pUSIhbJDtjx56xv7En3xDyzLBM6IGTodBpHg5cbEOYZhkq62ysWWqdvy4YT9Rob_BuX-6vkZftvzA1P0R34IaW4ddrNHA8kD5n5XNb9hiPtLxELoO5C0zc8Prjb_IoIVTjbomQCaYaXiGM4-leXd2NLkDMi5GS5xGs34J2rpNPbefryJPD3nKR9uzZH7yO__t1N8hGg03pq1qZbpI1V94iV8bN7ftt8mPocjcvjt3Pb9_BlQelyCguDPOZOaowtfHXFxTJPkDGMWBy6rPswNZIq5wuYHGaGVAJ-sV8RgFHxaGjBzXpdXEGkpByuYKmKP4ojPxN7pTiKTE1FDmVaekOPEk5xSj4qoShotvTkwJEjSbD53fI3s6b6XAUNskdQgsYT4Y6F8pZbZTRgHBg_7Qi4gMVZ5JbyxTPecqkQ3o63o9NLqyTKcJP0ecZLDNM3CXrJTR2n9DcxVlu0lhgIqaUayNyayKZSgn-UhpnAXnaTnIyrzk8ktb3gWFO_DAHZKud_qQx49OEM2xPad4PyJOuGAwQb1VM6aol1uERxvBGIOJerS1dKwIzDDOuAhKt6FFXAcm9V0vKYuZJviMBnRI6INteTf7e8eTDcOIfNv-96mNydTQd7ya7byfvH5BrAAJ1fay0RdYXJ0v3EIDWIn3k7ekXPOwpiQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSouvB8LBQziUA5Zre3YieGEFlbLo6sKtVIPSJHtON2obRK1uyB64idw59_xS5jJiy4VEuIWyc7YsWfsb-zJN4Q8MywVOvQyENpmQehjF8A0y0A572LNrPP1dcH2TE33wnf7cn-NvOz-hWn4IfoDN7SMer1GA6_S7JyRV64YMh5peYlcDhUgX0REH39zRwmhWm9LBEww1dIKYRhP_-rqZnQBYV4MlDwPYOsdaHKNfOr63gSeHA6XCzt0Z3_QOv7nx10nV1tkSl81qnSDrPniJtnYbu_eb5EfY5_5Kj_2P799B0ceVCKluCxUc3NUYmLjry8oUn2AjGNA5LTOsQMbIy0zuoClaW5AIegX8xkFHOWHnh40lNf5GUhCwuUSmqL4mzCyN_lTimfE1FBkVKaFP6gpyinGwJcFjBTd2j3JQdR0Nn5-m-xN3uyOp0Gb2iFwgPBkoDOhvNNGGQ34BnZPJyIeqjiV3DmmeMYtkx7J6fgoNplwXloEn2LEU1hkmLhD1gto7B6hmY_TzNhYYBomy7URmTORtFKCt2TjdECednOcVA2DR9J5PjDMST3MA7LZzX7SGvFpwhm2pzQfDciTvhjMD-9UTOHLJdbhEUbwRiDibqMsfSsC8wszrgYkWlGjvgJSe6-WFPm8pviOBHRK6AHZqrXk7x1Pdsaz-uH-v1d9TDZ2Xk-SD29n7x-QK4AAdXOmtEnWFydL_xBQ1sI-qq3pF7ZeKDg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cefepime%E2%80%90induced+encephalopathy%3A+Neural+mass+modeling+of+triphasic+wave%E2%80%90like+generalized+periodic+discharges+with+a+high+negative+component+%28Tri%E2%80%90HNC%29&rft.jtitle=Psychiatry+and+clinical+neurosciences&rft.au=Tamune%2C+Hidetaka&rft.au=Hamamoto%2C+Yu&rft.au=Aso%2C+Naofumi&rft.au=Yamamoto%2C+Naoki&rft.date=2019-01-01&rft.pub=John+Wiley+%26+Sons+Australia%2C+Ltd&rft.issn=1323-1316&rft.eissn=1440-1819&rft.volume=73&rft.issue=1&rft.spage=34&rft.epage=42&rft_id=info:doi/10.1111%2Fpcn.12795&rft.externalDBID=10.1111%252Fpcn.12795&rft.externalDocID=PCN12795 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-1316&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-1316&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-1316&client=summon |